Opyl Partners with L39 Capital to Launch AI Biotech Fund
Filed with ASX · · 4 pages · English
Earlier from Pathkey.AI
- Opyl Announces First Trial Gen Revenue & Customer
- Opyl signs binding agreement for sale of Opin business
- Reinstatement to Quotation
- Opyl receives non-binding offer for its Opin business
- Suspension from Quotation
Later from Pathkey.AI
- OPL signs MOU for EMEA & US Expansion
- Opyl - Business Update & Appendix 4C
- Opyl Secures $700K loans to advance TrialKey & Drive Growth
- Opyl - Appendix 4E
- Opyl - Full Year Results
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI